Conferences

ecancer travels so that you don't have to. Expore the latest conference coverage in global oncology and find out where we are going next.
Bookmark and Share

SABCS 2016

6 - 10 Dec 2016
Henry B. Gonzalez Convention Center, San Antonio, United States of America
A phase III study of buparlisib and fulvestrant in HR positive advanced breast c...
Dr Ruth O'Regan - University of Wisconsin-Madison, Madison, USA
A phase III study of buparlisib and fulvestrant in HR positive advanced breast cancer ( Dr Ruth O'Regan - University of Wisconsin-Madison, Madison, USA )
14 Dec 2016
Five years of letrozole does not improve disease free survival for pretreated HR...
Dr Terry Mamounas - UF Health Center, Orlando, USA
Five years of letrozole does not improve disease free survival for pretreated HR positive breast cancer ( Dr Terry Mamounas - UF Health Center, Orlando, USA )
14 Dec 2016
Reducing chemo-associated hair loss with scalp cooling cap
Dr Julie Rani Nangia - Baylor College of Medicine, Houston, USA
Reducing chemo-associated hair loss with scalp cooling cap ( Dr Julie Rani Nangia - Baylor College of Medicine, Houston, USA )
14 Dec 2016
Decoding breast cancer predisposition genes
Dr Fergus Couch - Mayo Clinic, Rochester, USA
Decoding breast cancer predisposition genes ( Dr Fergus Couch - Mayo Clinic, Rochester, USA )
14 Dec 2016
Macrophage iron recycling in triple negative breast cancer
Dr Lisa Privette Vinnedge - Cincinnati Children's Hospital, Cincinnati, USA
Macrophage iron recycling in triple negative breast cancer ( Dr Lisa Privette Vinnedge - Cincinnati Children's Hospital, Cincinnati, USA )
14 Dec 2016
Results of the BELLE-3 study of buparlisib for advanced breast cancer
Dr Ruth O'Regan - University of Wisconsin-Madison, Madison, USA
Results of the BELLE-3 study of buparlisib for advanced breast cancer ( Dr Ruth O'Regan - University of Wisconsin-Madison, Madison, USA )
14 Dec 2016
Epirubicin and cyclophosphamide before docetaxel in early breast cancer
Dr Bent Ejlertsen - Rigshospitalet Copenhagen, Denmark
Epirubicin and cyclophosphamide before docetaxel in early breast cancer ( Dr Bent Ejlertsen - Rigshospitalet Copenhagen, Denmark )
14 Dec 2016
Matched mutations and long term letrozole for breast cancer
Dr Virginia Kaklamani - UT Health Science Center, San Antonio, USA
Matched mutations and long term letrozole for breast cancer ( Dr Virginia Kaklamani - UT Health Science Center, San Antonio, USA )
14 Dec 2016
neoMONARCH: CDK inhibition for HR positive, HER negative breast cancer
Dr Sara Hurvitz - Ronald Reagan UCLA Medical Center, Los Angeles, USA
neoMONARCH: CDK inhibition for HR positive, HER negative breast cancer ( Dr Sara Hurvitz -  Ronald Reagan UCLA Medical Center, Los Angeles, USA )
13 Dec 2016
Oestrogen deprivation inffective with chemo for HR/HER positive breast cancer
Dr Mothaffar Rimawi - Baylor College of Medicine, Houston, USA
Oestrogen deprivation inffective with chemo for HR/HER positive breast cancer ( Dr Mothaffar Rimawi - Baylor College of Medicine, Houston, USA )
13 Dec 2016
No benefit for adjuvant ibandronate at 3 years in early breast cancer
Prof Sabine Linn - Netherlands Cancer Institute, Amsterdam, The Netherlands
No benefit for adjuvant ibandronate at 3 years in early breast cancer ( Prof Sabine Linn - Netherlands Cancer Institute, Amsterdam, The Netherlands )
13 Dec 2016
PARP inhibitory velaparib trialled in BRCA1/2 breast cancer
Dr Heather Han - H. Lee Moffitt Cancer Center, Tampa, USA
PARP inhibitory velaparib trialled in BRCA1/2 breast cancer ( Dr Heather Han - H. Lee Moffitt Cancer Center, Tampa, USA )
13 Dec 2016
Matched mutations in the progression of metastatic breast cancer
Dr Ofir Cohen - Broad Institute of MIT and Harvard, Cambridge, USA
Matched mutations in the progression of metastatic breast cancer ( Dr Ofir Cohen - Broad Institute of MIT and Harvard, Cambridge, USA )
13 Dec 2016
Expert discussion on CDK 4/6 inhibition in breast cancer
Prof Richard Finn, Prof Michael Gnant, Dr Mark Harries and Prof Sandra Swain
Expert discussion on CDK 4/6 inhibition in breast cancer ( Prof Richard Finn, Prof Michael Gnant, Dr Mark Harries and Prof Sandra Swain )
12 Dec 2016
PD-1 therapy with eribulin for triple negative MBC
Dr Sara Tolaney - Dana–Farber Cancer Institute, Boston, USA
PD-1 therapy with eribulin for triple negative MBC ( Dr Sara Tolaney - Dana–Farber Cancer Institute, Boston, USA )
9 Dec 2016
Women experiencing menopause symptoms less likely to adhere to medication
Dr Samuel Smith - University of Leeds, Leeds, UK
Women experiencing menopause symptoms less likely to adhere to medication ( Dr Samuel Smith - University of Leeds, Leeds, UK )
9 Dec 2016
Breast cancer mortality declining globally
Dr Cécile Pizot - International Prevention Research Institute, Lyon, France
Breast cancer mortality declining globally ( Dr Cécile Pizot - International Prevention Research Institute, Lyon, France )
9 Dec 2016
Everolimus extends PFS for HR positive, HER2 negative breast cancer
Dr Noah Kornblum - Montefiore Medical Center, New York, USA
Everolimus extends PFS for HR positive, HER2 negative breast cancer ( Dr Noah Kornblum - Montefiore Medical Center, New York, USA )
9 Dec 2016
TEAM IIb trial results: Adjuvant ibandronate in early breast cancer
Prof Sabine Linn - Netherlands Cancer Institute, Amsterdam, The Netherlands
TEAM IIb trial results: Adjuvant ibandronate in early breast cancer ( Prof Sabine Linn - Netherlands Cancer Institute, Amsterdam, The Netherlands )
9 Dec 2016
Neoadjuvant abemaciclib for HR positive, HER negative breast cancer
Dr Sara Hurvitz - Ronald Reagan UCLA Medical Center, Los Angeles, USA
Neoadjuvant abemaciclib for HR positive, HER negative breast cancer ( Dr Sara Hurvitz -  Ronald Reagan UCLA Medical Center, Los Angeles, USA )
8 Dec 2016
TCHP with/out oestrogen for HR/HER positive breast cancer
Dr Mothaffar Rimawi - Baylor College of Medicine, Houston, USA
TCHP with/out oestrogen for HR/HER positive breast cancer ( Dr Mothaffar Rimawi - Baylor College of Medicine, Houston, USA )
8 Dec 2016
Efficacy of veliparib with carboplatin and paclitaxel for BRCA1/2 mutations in m...
Dr Heather Han - H. Lee Moffitt Cancer Center, Tampa, USA
Efficacy of veliparib with carboplatin and paclitaxel for BRCA1/2 mutations in metastatic breast cancer ( Dr Heather Han - H. Lee Moffitt Cancer Center, Tampa, USA )
7 Dec 2016
Extended adjuvant endrocine therapy with letrozole after aromatase inhibition
Dr Terry Mamounas - UF Health Center, Orlando, USA
Extended adjuvant endrocine therapy with letrozole after aromatase inhibition ( Dr Terry Mamounas - UF Health Center, Orlando, USA )
7 Dec 2016
Whole exome and transcriptome sequencing of resistant ER positive metastatic bre...
Dr Ofir Cohen - Broad Institute of MIT and Harvard, Cambridge, USA
Whole exome and transcriptome sequencing of resistant ER positive metastatic breast cancer ( Dr Ofir Cohen - Broad Institute of MIT and Harvard, Cambridge, USA )
7 Dec 2016
PrECOG: Added everolimus extends PFS for HR positive, HER2 negative breast cance...
Dr Noah Kornblum - Montefiore Medical Center, New York, USA
PrECOG: Added everolimus extends PFS for HR positive, HER2 negative breast cancer ( Dr Noah Kornblum - Montefiore Medical Center, New York, USA )
7 Dec 2016